OLIG2 Antikörper

Produktnummer ABIN969331

Produktdetails anti-OLIG2 Antikörper

Target: OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser OLIG2 Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC), Immunocytochemistry (ICC)

Verwendungszweck: OLIG2 Antibody

Aufreinigung: Ascitic fluid

Immunogen: Purified recombinant fragment of human OLIG2 expressed in E. Coli.

Klon: 1G11

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise:

ELISA: 1/10000

ICC: 1/200 - 1/1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Ascitic fluid containing 0.03 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Referenzen für anti-OLIG2 Antikörper (ABIN969331)

Bonnet-Dupeyron, Combes, Boespflug-Tanguy, Vaurs-Barrière: "Absence of OLIG2 mutations in patients presenting with a severe Pelizaeus-Merzbacher-like leukodystrophy associated with motor neuron dysfunction." in: American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, Vol. 147B, Issue 4, pp. 538-9, (2008) (PubMed).

Mikami, Hirose, Yoshida, Kawase, Ohnishi, Nagashima, Mukai, Okada, Ikeda: "Predominant expression of OLIG2 over ID2 in oligodendroglial tumors." in: Virchows Archiv : an international journal of pathology, Vol. 450, Issue 5, pp. 575-84, (2007) (PubMed).

Details zu OLIG2

Target: OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))

Andere Bezeichnung: OLIG2 (OLIG2 Produkte)

Synonyme: olig3.2 antikoerper, MGC89336 antikoerper, OLIG2 antikoerper, BHLHB1 antikoerper, OLIGO2 antikoerper, PRKCBP2 antikoerper, RACK17 antikoerper, bHLHe19 antikoerper, wu:fc64g09 antikoerper, AI604895 antikoerper, Bhlhb1 antikoerper, Olg-2 antikoerper, Oligo2 antikoerper, RK17 antikoerper, oligodendrocyte transcription factor 4 antikoerper, oligodendrocyte transcription factor 2 antikoerper, oligodendrocyte lineage transcription factor 2 antikoerper, olig4 antikoerper, OLIG2 antikoerper, Olig2 antikoerper, olig2 antikoerper

Hintergrund:

Description: This gene encodes a basic helix-loop-helix transcription factor which is expressed in oligodendroglial tumors of the brain. The protein is an essential regulator of ventral neuroectodermal progenitor cell fate. The gene is involved in a chromosomal translocation t(14,21)(q11.2,q22) associated with T-cell acute lymphoblastic leukemia. Its chromosomal location is within a region of chromosome 21 which has been suggested to play a role in learning deficits associated with Down syndrome. Tissue specificity: Expressed in the brain, in oligodendrocytes. Strongly expressed in oligodendrogliomas, while expression is weak to moderate in astrocytomas. Expression in glioblastomas highly variable.

Aliases: BHLHB1, OLIGO2, RACK17, PRKCBP2, bHLHe19, OLIG2

Molekulargewicht: 32kDa

Gen-ID: 10215

HGNC: 10215

UniProt: Q13516